Related Experiment Video
Updated: Oct 8, 2025

Assessment of Child Anthropometry in a Large Epidemiologic Study
Published on: February 2, 2017
Obesity, Body Composition, and Sex Hormones: Implications for Cardiovascular Risk
Prachi Singh1, Naima Covassin2, Kara Marlatt1
1Pennington Biomedical Research Center, Louisiana State University System, Baton Rouge, Louisiana, USA.
Obesity and sex hormones significantly influence cardiovascular disease (CVD) risk. Understanding how sex hormones affect body composition can reveal new strategies for CVD risk reduction in both men and women.
Area of Science:
- Physiology
- Endocrinology
- Cardiovascular Medicine
Background:
- Cardiovascular disease (CVD) remains the primary cause of adult mortality.
- The escalating obesity epidemic poses a significant threat to established CVD risk reduction strategies.
- Sex-based differences in CVD risk emerge around menopause, suggesting a role for sex hormones.
Purpose of the Study:
- To explore the influence of obesity and sex hormones on cardiovascular disease (CVD) risk.
- To examine the role of sex hormones in determining body composition differences between sexes.
- To outline the potential clinical applications of sex hormones in modifying body composition and mitigating CVD risk.
Main Methods:
- Review of existing scientific literature and research findings.
- Analysis of data concerning sex differences in obesity, fat distribution, and CVD outcomes.
- Examination of evidence linking sex hormones to body composition and cardiovascular health.
Main Results:
- Significant sex differences exist in CVD risk, particularly around menopause.
- Men and women exhibit distinct patterns of obesity and regional fat distribution.
- Sex hormones play a crucial role in regulating body composition and may influence CVD risk.
Conclusions:
- Obesity and sex hormones are key determinants of cardiovascular disease risk.
- Understanding sex-specific effects on body composition offers potential therapeutic targets.
- Harnessing sex hormones may provide novel approaches to reduce cardiovascular risk and improve body composition.
More Related Videos
Related Concept Videos
Obesity
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
Cholesterol: Significance and Regulation
Considering cholesterol and...
Drug Dosing: Obese Patients
Overview of Lipid Metabolism
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

